Send Inquiry

Request To Call Back

Sigrima 420mg Pertuzumab Injection

Name: Sigrima 420mg Pertuzumab Injection
Brand: Amari Trade Alliance LLP
Price: 61000 INR
Availability: InStock

Price 61000 INR/ Unit

Get a Price/Quote

MOQ : 1 Piece

Sigrima 420mg Pertuzumab Injection Specification

Dosage Form
Lyophilized powder for concentrate for solution for infusion

Life Span
See packaging for expiration date

Packaging Type
Vial

Brand Name
Sigrima

Indication
HER2-positive metastatic breast cancer

Salt Composition
Pertuzumab

Origin of Medicine
India

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Biological

Ingredients
Pertuzumab 420mg

Physical Form
Injection

Function
Cancer treatment; anti-HER2 monoclonal antibody

Recommended For
Breast Cancer Treatment

Dosage
As directed by physician

Dosage Guidelines
To be administered by a healthcare professional

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store in a refrigerator (2C-8C). Do not freeze.

Strength
420mg/vial

Appearance
White to pale yellow lyophilized powder

Marketed By
Alkem Oncology

Therapeutic Class
Antineoplastic agent

ATC Code
L01XC13

Route of Administration
Intravenous infusion

Prescription Required
Yes

Dilution Required
Yes, before infusion

Usage
Hospital/institutional use only

Sigrima 420mg Pertuzumab Injection Trade Information

Minimum Order Quantity
1 Piece

Delivery Time
7 Days

About Sigrima 420mg Pertuzumab Injection

Experience the top choice in cancer care with Sigrima 420mg Pertuzumab Injection, renowned for its finest quality as an anti-HER2 monoclonal antibody. This new-generation product is specifically designed for adults battling HER2-positive metastatic breast cancer. Developed as a lyophilized powder with a gorgeous white to pale yellow appearance, Sigrima is available in a prime 420mg vial for intravenous infusion. Take advantage of this prescription-only, hospital-grade treatment, meticulously produced by Alkem Oncology in India, ensuring safe and optimal efficacy for institutional use.

Prime Use and Features of Sigrima 420mg Pertuzumab Injection

Sigrima 420mg Pertuzumab Injection is exclusively intended for hospital and institutional use under physician supervision. It is used as an antineoplastic agent in the treatment of HER2-positive metastatic breast cancer in adults. Key features include its biological drug composition, requirement for intravenous infusion after proper dilution, and meticulously controlled storage at 2C-8C. With its white to pale yellow lyophilized powder form, Sigrima ensures precision in preparation and administration, adhering to the highest safety standards.

Premium Sample Availability and Market Certification

Sigrima 420mg is available for evaluation through premium samples, ensuring healthcare providers can assess its efficacy and safety before making procurement decisions. Complete with necessary pharmaceutical certifications, this product is highly valued in the Indian domestic market. The sale price and valuation reflect Sigrima's commitment to delivering top-tier, quality-assured oncology solutions. Each single vial comes boxed and clearly labeled with expiry details, supporting transparency for hospitals, exporters, suppliers, and traders alike.

FAQ's of Sigrima 420mg Pertuzumab Injection:

Q: How should Sigrima 420mg Pertuzumab Injection be administered for optimal efficacy?

A: Sigrima 420mg Pertuzumab Injection must be diluted before intravenous infusion and should only be administered by a qualified healthcare professional in a hospital or institutional setting.

Q: What is the main usage of Sigrima 420mg Pertuzumab Injection?

A: This product is primarily used as an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer in adult patients.

Q: When is it necessary to prepare a fresh dilution of the Sigrima injection?

A: The Sigrima injection should be freshly diluted prior to each administration, following physician instructions, to ensure safety and effectiveness.

Q: Where should Sigrima 420mg Pertuzumab Injection be stored to maintain its quality?

A: This injection must be stored in a refrigerator between 2C and 8C. It should never be frozen to preserve its pharmaceutical integrity.

Q: What is the process for obtaining Sigrima 420mg for hospital use?

A: Only registered hospitals and institutional purchasers can obtain Sigrima, and it requires a valid prescription due to its specialized use in cancer therapy.

Q: What benefits does Sigrima offer in breast cancer treatment?

A: Sigrima delivers targeted therapy for HER2-positive metastatic breast cancer, contributing to improved patient outcomes when used in combination with other treatment modalities, as prescribed by healthcare professionals.

Tell us about your requirement